IN2015DN02894A - - Google Patents

Info

Publication number
IN2015DN02894A
IN2015DN02894A IN2894DEN2015A IN2015DN02894A IN 2015DN02894 A IN2015DN02894 A IN 2015DN02894A IN 2894DEN2015 A IN2894DEN2015 A IN 2894DEN2015A IN 2015DN02894 A IN2015DN02894 A IN 2015DN02894A
Authority
IN
India
Prior art keywords
disease
field
relates
airway
pulmonary disease
Prior art date
Application number
Other languages
English (en)
Inventor
Balazs; Albrecht
Michael; Aven
Janine; Lamar
Ingo; Lang
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN02894(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of IN2015DN02894A publication Critical patent/IN2015DN02894A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
IN2894DEN2015 2012-12-21 2013-12-18 IN2015DN02894A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
PCT/EP2013/077265 WO2014096115A1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses

Publications (1)

Publication Number Publication Date
IN2015DN02894A true IN2015DN02894A (da) 2015-09-11

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2894DEN2015 IN2015DN02894A (da) 2012-12-21 2013-12-18

Country Status (24)

Country Link
US (4) US20140179651A1 (da)
EP (1) EP2934479B1 (da)
AR (1) AR094241A1 (da)
AU (2) AU2013360691B2 (da)
BR (2) BR112015010842B1 (da)
CA (1) CA2888428C (da)
CY (2) CY1121115T1 (da)
DK (1) DK2934479T3 (da)
ES (1) ES2693779T3 (da)
FR (1) FR20C1026I1 (da)
HR (1) HRP20181980T1 (da)
HU (1) HUS2000020I1 (da)
IN (1) IN2015DN02894A (da)
LT (2) LT2934479T (da)
MA (1) MA38169B2 (da)
MX (1) MX368306B (da)
NO (1) NO2020014I1 (da)
NZ (1) NZ706573A (da)
PL (1) PL2934479T3 (da)
PT (1) PT2934479T (da)
RS (1) RS57740B1 (da)
SI (1) SI2934479T1 (da)
WO (1) WO2014096115A1 (da)
ZA (1) ZA201502288B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR089645A1 (es) 2011-08-12 2014-09-10 Boehringer Ingelheim Vetmed Particula multicapas de sabor enmascarado, metodo, uso, composicion farmaceutica
ES2909039T3 (es) 2012-12-21 2022-05-05 Boehringer Ingelheim Vetmedica Gmbh Formulación farmacéutica que comprende ciclesonida
IN2015DN02894A (da) 2012-12-21 2015-09-11 Boehringer Ingelheim Vetmed
AU2015276310B2 (en) 2014-06-18 2020-01-16 Boehringer Ingelheim Vetmedica Gmbh Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
KR102035478B1 (ko) * 2016-10-14 2019-10-23 제주대학교 산학협력단 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물
WO2021140113A1 (en) * 2020-01-10 2021-07-15 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for ameliorating quality of life (qol) in equines
FI4188327T3 (fi) 2020-07-31 2025-07-25 Chemo Res S L Yhdistelmähoito inhalaatioannosteluun

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
AU2003272450A1 (en) 2002-09-13 2004-04-30 C. Steven Smith Novel composition and method for treatment of upper respiratory conditions
US20060293293A1 (en) * 2003-05-22 2006-12-28 Altana Pharma Ag Salmeterol and ciclesonide combination
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
WO2006003078A1 (en) 2004-06-29 2006-01-12 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2010149280A1 (en) 2009-06-25 2010-12-29 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US7829748B1 (en) 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
WO2014007766A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
EA201590030A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
IN2015DN02894A (da) 2012-12-21 2015-09-11 Boehringer Ingelheim Vetmed
ES2909039T3 (es) 2012-12-21 2022-05-05 Boehringer Ingelheim Vetmedica Gmbh Formulación farmacéutica que comprende ciclesonida
WO2015024651A1 (en) 2013-08-20 2015-02-26 Boehringer Ingelheim Vetmedica Gmbh Inhaler
MX377423B (es) 2013-08-20 2025-03-10 Boehringer Ingelheim Vetmedica Gmbh Inhalador.
AU2015276310B2 (en) 2014-06-18 2020-01-16 Boehringer Ingelheim Vetmedica Gmbh Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

Also Published As

Publication number Publication date
US10441597B2 (en) 2019-10-15
CA2888428A1 (en) 2014-06-26
US20180153907A1 (en) 2018-06-07
CY2020015I2 (el) 2021-03-12
LTPA2020511I1 (lt) 2020-07-27
AU2013360691A1 (en) 2015-04-16
RS57740B1 (sr) 2018-12-31
HRP20181980T1 (hr) 2019-01-25
PT2934479T (pt) 2018-12-20
US9918995B2 (en) 2018-03-20
BR122016029247A2 (pt) 2019-08-20
MX2015007947A (es) 2015-10-08
MX368306B (es) 2019-09-27
AU2018201642B2 (en) 2019-01-31
WO2014096115A1 (en) 2014-06-26
US20140179651A1 (en) 2014-06-26
CY1121115T1 (el) 2019-12-11
HUS2000020I1 (hu) 2020-07-28
US20170079988A1 (en) 2017-03-23
EP2934479B1 (en) 2018-09-19
MA38169B2 (fr) 2021-08-31
PL2934479T3 (pl) 2019-02-28
NZ706573A (en) 2019-11-29
US20150313918A1 (en) 2015-11-05
DK2934479T3 (da) 2018-11-05
ES2693779T3 (es) 2018-12-13
SI2934479T1 (sl) 2019-01-31
AR094241A1 (es) 2015-07-22
US10258634B2 (en) 2019-04-16
CA2888428C (en) 2021-07-13
MA38169A1 (fr) 2017-01-31
AU2013360691B2 (en) 2018-03-08
NO2020014I1 (no) 2020-06-12
CY2020015I1 (el) 2020-11-25
AU2018201642A1 (en) 2018-03-29
FR20C1026I1 (fr) 2020-10-02
BR112015010842A8 (pt) 2019-10-01
LT2934479T (lt) 2018-12-27
ZA201502288B (en) 2019-09-25
EP2934479A1 (en) 2015-10-28
BR112015010842A2 (pt) 2017-07-11
BR112015010842B1 (pt) 2021-03-30

Similar Documents

Publication Publication Date Title
ZA202004764B (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
HUE053113T2 (hu) Bardoxolon-metil 2,2-difluorpropionamid-származéka, annak gyógyszerkészítményei és polimorfjai bizonyos betegségek kezelésében történõ alkalmazásra
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
NZ706573A (en) Ciclesonide for the treatment of airway disease in horses
MX2014000341A (es) Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades.
WO2014179564A8 (en) Thiazolopyrrolidine inhibitors of ror-gamma
IN2014DN09352A (da)
PL2444081T3 (pl) Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
MX2015017964A (es) Inhibidores de bromodominio.
MX2019014935A (es) Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.
LT2726511T (lt) Kompozicijos, panaudojimai ir būdai, skirti metabolinių sutrikimų ir ligų gydymui
WO2014151456A3 (en) Treatment of inflammatory diseases
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
EA032951B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
IN2014DN09347A (da)
HK1217092A1 (zh) 治疗性化合物及其用途
PH12012501389A1 (en) Hedgehog inhibitors
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
MX2015001657A (es) Compuestos de cianopirazol substituidos con receptores de acido lisofosfatidico (lpar).
WO2014138616A3 (en) Pyrazole compounds and methods of use thereof
WO2015003049A3 (en) Compositions and methods to treat inflammatory joint disease
IN2013MU03429A (da)